70518-1585 Ondansetron Hydrochloride

Product NDC:

70518-1585

Brand Name:

Ondansetron Hydrochloride

Generic Name:

Ondansetron Hydrochloride

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: ONDANSETRON HYDROCHLORIDE

Strength: 4.0

Unit: mg/1

Packages:

Code: 70518-1585-00

Description: 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-1585-0)

Effective Date: Oct. 24, 2018

Discontinued:

Code: 70518-1585-01

Description: 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-1585-1)

Effective Date: Jan. 6, 2021

Discontinued: Aug. 11, 2021

Code: 70518-1585-03

Description: 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-1585-3)

Effective Date: Aug. 1, 2023

Discontinued:

Code: 70518-1585-02

Description: 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-1585-2)

Effective Date: Feb. 3, 2021

Discontinued: March 9, 2021

Code: 70518-1585-05

Description: 15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-1585-5)

Effective Date: Aug. 16, 2023

Discontinued:

Code: 70518-1585-04

Description: 16 TABLET, FILM COATED in 1 BLISTER PACK (70518-1585-4)

Effective Date: Aug. 9, 2023

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

Government Funding Lapse

CanMED: NDC

CanMED and the Oncology Toolbox

CanMED: NDC